Verona Pharma PLC
NASDAQ:VRNA

Watchlist Manager
Verona Pharma PLC Logo
Verona Pharma PLC
NASDAQ:VRNA
Watchlist
Price: 35.37 USD -4.22% Market Closed
Market Cap: 2.9B USD
Have any thoughts about
Verona Pharma PLC?
Write Note

Verona Pharma PLC
Total Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Verona Pharma PLC
Total Liabilities Peer Comparison

Comparables:
GSK
AZN
INDV
HIK
DPH

Competitive Total Liabilities Analysis
Latest Figures & CAGR of Competitors

Company Total Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
Verona Pharma PLC
NASDAQ:VRNA
Total Liabilities
$251.3m
CAGR 3-Years
96%
CAGR 5-Years
70%
CAGR 10-Years
N/A
GlaxoSmithKline PLC
LSE:GSK
Total Liabilities
ÂŁ43.7B
CAGR 3-Years
-11%
CAGR 5-Years
-6%
CAGR 10-Years
3%
AstraZeneca PLC
LSE:AZN
Total Liabilities
$64.8B
CAGR 3-Years
4%
CAGR 5-Years
6%
CAGR 10-Years
6%
Indivior PLC
LSE:INDV
Total Liabilities
$1.7B
CAGR 3-Years
5%
CAGR 5-Years
4%
CAGR 10-Years
13%
Hikma Pharmaceuticals PLC
LSE:HIK
Total Liabilities
$2.6B
CAGR 3-Years
11%
CAGR 5-Years
8%
CAGR 10-Years
11%
Dechra Pharmaceuticals PLC
LSE:DPH
Total Liabilities
ÂŁ814.2m
CAGR 3-Years
11%
CAGR 5-Years
10%
CAGR 10-Years
13%

See Also

What is Verona Pharma PLC's Total Liabilities?
Total Liabilities
251.3m USD

Based on the financial report for Sep 30, 2024, Verona Pharma PLC's Total Liabilities amounts to 251.3m USD.

What is Verona Pharma PLC's Total Liabilities growth rate?
Total Liabilities CAGR 5Y
70%

Over the last year, the Total Liabilities growth was 769%. The average annual Total Liabilities growth rates for Verona Pharma PLC have been 96% over the past three years , 70% over the past five years .

Back to Top